Sex lives of menopausal women and their partners

Posted on: 19 November 2012 by 50connect editorial

New research to mark World Menopause Day


About vaginal atrophy

Vaginal atrophy, a chronic condition, is the thinning and inflammation of the vaginal wall which occurs when there is a reduction in levels of oestrogens5. Oestrogen, produced by the ovaries, is responsible for maintaining the structure and function of the vaginal wall, elasticity of the tissues around the vagina and production of vaginal fluid. If left untreated, vaginal atrophy can have long-term urogenital effects, including incontinence6.

About the CLOSER research

The CLOSER research was an online survey conducted by StrategyOne (partnering with Ipsos MORI) between 13 December 2011 and 7 February 2012. The survey was completed by 4,100 post-menopausal women, aged between 55-65 who had ceased menstruating for at least 12 months and have experienced vaginal atrophy, and 4,100 male partners of post-menopausal women aged 55-65 who have ceased menstruating for at least 12 months and have experienced vaginal atrophy. The participants were located across nine countries: US, UK, Canada, Denmark, Sweden, Finland, Norway, Italy and France.3,4

The objectives of this research were to better understand the impact that vaginal atrophy has on intimacy and relationships, both physically and emotionally, and to find out how to encourage positive conversations among men and women about this topic. The research also looked at the positive impact that local oestrogen treatment can have on the sufferer’s relationship. The global results were first presented at the European Menopause and Andropause Society (EMAS) in March 20124 and the UK data was first presented at the British Menopause Society (BMS) Annual Conference in July 2012.3

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit

Share with friends

Do you agree with this Article? Agree 0% Disagree 0%
You need to be signed in to rate.

Loading comments...Loader